JPWO2019218015A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019218015A5 JPWO2019218015A5 JP2021514456A JP2021514456A JPWO2019218015A5 JP WO2019218015 A5 JPWO2019218015 A5 JP WO2019218015A5 JP 2021514456 A JP2021514456 A JP 2021514456A JP 2021514456 A JP2021514456 A JP 2021514456A JP WO2019218015 A5 JPWO2019218015 A5 JP WO2019218015A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- rrrrrrrrr
- optionally
- acid sequence
- rskaknply
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018901672A AU2018901672A0 (en) | 2018-05-15 | Activating Agents | |
| AU2018901672 | 2018-05-15 | ||
| PCT/AU2019/050462 WO2019218015A1 (en) | 2018-05-15 | 2019-05-15 | Activating agents |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021523945A JP2021523945A (ja) | 2021-09-09 |
| JP2021523945A5 JP2021523945A5 (https=) | 2022-05-24 |
| JPWO2019218015A5 true JPWO2019218015A5 (https=) | 2022-05-24 |
| JP7644000B2 JP7644000B2 (ja) | 2025-03-11 |
Family
ID=68539125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514456A Active JP7644000B2 (ja) | 2018-05-15 | 2019-05-15 | 活性化剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12134663B2 (https=) |
| EP (1) | EP3794015A4 (https=) |
| JP (1) | JP7644000B2 (https=) |
| KR (1) | KR20210021311A (https=) |
| CN (1) | CN112368293A (https=) |
| AU (1) | AU2019268411B2 (https=) |
| CA (1) | CA3100072A1 (https=) |
| WO (1) | WO2019218015A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11912789B2 (en) | 2018-05-15 | 2024-02-27 | Interk Peptide Therapeutics Limited | Peptide activating agent |
| CA3120624A1 (en) * | 2018-11-30 | 2020-06-04 | Interk Peptide Therapeutics Limited | Polypeptides and methods for improving skin conditions |
| EP4244234A4 (en) * | 2020-11-10 | 2024-12-25 | InterK Peptide Therapeutics Limited | POLYPEPTIDES AND METHODS FOR IMPROVING SKIN DISEASES |
| JP2024532850A (ja) * | 2021-08-20 | 2024-09-10 | インテルク ペプチド セラピューティクス リミテッド | がん及びがん療法に関連する自己免疫を含む、自己免疫を処置するための組成物及び方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1226552B (it) * | 1988-07-29 | 1991-01-24 | Ellem Ind Farmaceutica | Peptidi immunostimolanti. |
| US20030162956A1 (en) | 1997-04-07 | 2003-08-28 | Human Genome Sciences, Inc. | Leukocyte regulatory factors 1 and 2 |
| AUPR230500A0 (en) * | 2000-12-22 | 2001-01-25 | University Of Newcastle Research Associates Limited, The | A method of modulating map kinase mediated cellular activity and agents useful in same |
| US20030194798A1 (en) | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
| ATE541940T1 (de) | 2001-10-15 | 2012-02-15 | Engeneic Molecular Delivery Pty Ltd | Intakte minizellen als vektoren für dna-transfer und gentherapie in vitro und in vivo |
| WO2005009346A2 (en) | 2003-06-24 | 2005-02-03 | Mirus Corporation | Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |
| US7611885B2 (en) | 2003-06-24 | 2009-11-03 | Engeneic Molecular Delivery Pty, Ltd. | Pharmaceutically compatible method for purifying intact bacterial minicells |
| JP2007522094A (ja) * | 2003-09-22 | 2007-08-09 | アシドフィル エルエルシー | 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法 |
| US20060194319A1 (en) | 2004-09-02 | 2006-08-31 | Webb Carol F | Promoter substitution for immunoglobulin therapy |
| WO2006029981A1 (en) | 2004-09-13 | 2006-03-23 | Vib Vzw | Abin-mediated protection against lung inflammatory disease |
| DK2229956T3 (da) | 2004-09-13 | 2013-07-29 | Genzyme Corp | Multimere konstruktioner |
| US7429481B2 (en) | 2004-09-14 | 2008-09-30 | University Of Pittsburgh | Targeting viruses using a modified sindbis glycoprotein |
| WO2009021137A2 (en) * | 2007-08-07 | 2009-02-12 | Purdue Research Foundation | Kinase inhibitors and uses thereof |
| CN101854945B (zh) * | 2007-09-18 | 2015-07-01 | 株式会社绿多肽 | Ctl诱导剂组合物 |
| SI2119726T2 (en) * | 2008-05-14 | 2018-03-30 | Immatics Biotechnologies Gmbh | New and powerful Class II MHC peptides derived from survivin and neurocane |
| EP2378875B1 (en) * | 2008-12-10 | 2018-05-30 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| WO2010094085A1 (en) * | 2009-02-23 | 2010-08-26 | Inter-K Pty Limited | Inhibition of multiple cell activation pathways |
| WO2012033911A2 (en) * | 2010-09-08 | 2012-03-15 | The Johns Hopkins University | Polyionic papilloma virus-like particle (vlp) vaccines |
| US20140186372A1 (en) * | 2011-06-16 | 2014-07-03 | La Jolla Institute For Allergy And Immunology | Compositions targeting pkc-theta and uses and methods of treating pkc-theta pathologies, adverse immune responses and diseases |
| WO2013033838A1 (en) | 2011-09-09 | 2013-03-14 | Pharmagap Inc. | Liposomal formulations of cationic peptides and uses thereof |
| US9403877B2 (en) * | 2012-01-24 | 2016-08-02 | Inter-K Pty Limited | Peptide agents for cancer therapy |
| WO2015053338A1 (ja) * | 2013-10-08 | 2015-04-16 | 学校法人東京理科大学 | カチオン性ペプチドおよびそれを含む医薬組成物 |
| JP6367600B2 (ja) | 2014-04-18 | 2018-08-01 | 矢崎総業株式会社 | コネクタ |
| CN110997693A (zh) | 2017-06-07 | 2020-04-10 | 阿德克斯公司 | τ聚集抑制剂 |
-
2019
- 2019-05-15 CN CN201980043872.7A patent/CN112368293A/zh active Pending
- 2019-05-15 CA CA3100072A patent/CA3100072A1/en active Pending
- 2019-05-15 US US17/055,250 patent/US12134663B2/en active Active
- 2019-05-15 AU AU2019268411A patent/AU2019268411B2/en active Active
- 2019-05-15 JP JP2021514456A patent/JP7644000B2/ja active Active
- 2019-05-15 WO PCT/AU2019/050462 patent/WO2019218015A1/en not_active Ceased
- 2019-05-15 KR KR1020207036028A patent/KR20210021311A/ko active Pending
- 2019-05-15 EP EP19803532.1A patent/EP3794015A4/en not_active Withdrawn
-
2024
- 2024-09-27 US US18/899,187 patent/US20260103488A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523945A5 (https=) | ||
| JP2014521684A5 (https=) | ||
| CA2112907C (en) | Peptide which abrogates tnf and/or lps toxicity | |
| Redman et al. | Pharmacokinetic and chemical synthesis optimization of a potent D-peptide HIV entry inhibitor suitable for extended-release delivery | |
| JP2021523946A5 (https=) | ||
| JPWO2019218015A5 (https=) | ||
| US11299518B2 (en) | Fusion respiratory syncytial virus inhibitors and use thereof | |
| JPWO2019218016A5 (https=) | ||
| AU2020302077B2 (en) | Compositions and methods for treatment of fungal infections | |
| US20240180997A1 (en) | Peptide inhibitors of nf kappa b and use thereof in treatment of covid-19 and inflammatory diseases | |
| US20180201647A1 (en) | Peptoid | |
| JPWO2018038168A1 (ja) | ヘマグルチニン結合ペプチド、および、これを含むインフルエンザウイルス感染症の予防・治療薬 | |
| US6828304B1 (en) | Peptides for treatment of cancer | |
| JP2009515933A (ja) | インフルエンザにおけるインターフェロン | |
| US6596692B1 (en) | Substance P analogs for the treatment of cancer | |
| JP4332618B2 (ja) | 抗ｈｉｖ剤 | |
| JP2014198711A (ja) | Ｃｔ阻害４価ペプチドおよびコレラ治療薬 | |
| US20240391970A1 (en) | Compositions and methods for treatment of fungal infections | |
| TW476650B (en) | Use of a cytokine regulatory agent to treat rheumatoid arthritis | |
| WO1997048725A1 (en) | Novel peptides for prevention and treatment of infection | |
| WO2013111129A1 (en) | Stabilized peptide helices for inhibiting dimerization of chemokine c motif receptor 2 (ccr2) | |
| JP6578546B2 (ja) | Ｌｔ阻害４価ペプチドおよびｅｔｅｃ感染症治療薬 | |
| US7314867B2 (en) | Pharmaceutical composition comprising a retro-iverso isomer peptide | |
| OA22102A (en) | Membrane fusion inhibitor for inhibiting aids virus and drug-resistant strain thereof, and pharmaceutical use thereof. | |
| KR20250158924A (ko) | Crf2 수용체 작용제와 그 아실화 결합체의 용도 |